A composite model for hERG blockade

被引:46
作者
Kramer, Christian [1 ,2 ,3 ]
Beck, Bernd [1 ]
Kriegl, Jan M. [1 ]
Clark, Timothy [2 ,3 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Discovery, D-88397 Biberach, Germany
[2] Univ Erlangen Nurnberg, Comp Chemie Ctr, D-91052 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Interdisciplinary Ctr Mol Mat, D-91052 Erlangen, Germany
关键词
hERG; ion channels; semi-empirical calculations; structure-activity relationships; toxicology;
D O I
10.1002/cmdc.200700221
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
hERG blockade is one of the major toxicological problems in lead structure optimization. Reliable ligand-based in silica models for predicting hERG blockade therefore have considerable potential for saving time and money, as patch-clamp measurements are very expensive and no crystal structures of the hERG-encoded channel are available. Herein we present a predictive QSAR model for hERG blockade that differentiates between specific and nonspecific binding. Specific binders are identified by preliminary pharmacophore scanning. In addition to descriptor-based models for the compounds selected as hitting one of two different pharmocophores, we also use a model for nonspecific binding that reproduces blocking properties of molecules that do not fit either of the two pharmacophores. PLS and SVR models based on interpretable quantum mechanically derived descriptors on a literature dataset of 773 molecules reach overall R-2 values between 0.60 and 0.70 for independent validation sets and R-2 values between 0.39 and 0.76 after partitioning according to the pharmacophore search for the test sets. Our findings suggest that hERG blockade may occur through different types of binding, so that several different models may be necessary to assess hERG toxicity.
引用
收藏
页码:254 / 265
页数:12
相关论文
共 84 条
[1]  
*ACC SOFTW INC, 2003, TSAR VERS 3 3
[2]  
*ACC SOFTW INC, 2003, CAT SOFTW PACK VERS
[3]  
[Anonymous], LIBSVM LIB SUPPORT V
[4]   Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers [J].
Aronov, Alex M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6917-6921
[5]   A model for identifying HERG K+ channel blockers [J].
Aronov, AM ;
Goldman, BB .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) :2307-2315
[6]   Predictive in silico modeling for hERG channelblockers [J].
Aronov, MM .
DRUG DISCOVERY TODAY, 2005, 10 (02) :149-155
[7]   HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study [J].
Bains, W ;
Basman, A ;
White, C .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2004, 86 (02) :205-233
[8]  
Beck B, 1997, J COMPUT CHEM, V18, P744, DOI 10.1002/(SICI)1096-987X(19970430)18:6<744::AID-JCC2>3.0.CO
[9]  
2-S
[10]   MOLECULAR MECHANISM FOR AN INHERITED CARDIAC-ARRHYTHMIA [J].
BENNETT, PB ;
YAZAWA, K ;
MAKITA, N ;
GEORGE, AL .
NATURE, 1995, 376 (6542) :683-685